Business description: C-Rad AB

C-Rad AB is a Sweden-based holding company active in the medical equipment industry. It offers products and solutions to the radiation therapy market. C-Rad AB is the parent company within the C-Rad group (the Group). The Group provides such products, as Sentinel, a surface contour laser scanning system for patient positioning, monitoring and gating applications; Catalyst, a surface scanning system, which allows the identification and tracking of markers, and GEMini, a system based on a gaseous detector using metal converters interleaved with Gas Electron Multipliers (GEMs), as well as other products. The Company operates through several subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB, C-RAD Innovation AB and Cyrpa International Sprl. The Company’s largest shareholder is Inter Life Science AB.

Number of employees: 98

Sales by Activity: C-Rad AB

Fiscal Period: December 2021 (SEK) 2022 (SEK) 2023 (SEK) 2024 (SEK) 2025 (SEK)

Positioning

261M 301M 425M 469M 442M

Geographical breakdown of sales: C-Rad AB

Fiscal Period: December 2021 (SEK) 2022 (SEK) 2023 (SEK) 2024 (SEK) 2025 (SEK)

EMEA (Excluding Sweden)

- - - - 168M

APAC

- - 119M 210M 167M

Americas

- - 85.97M 72.7M 98.75M

Sweden

21.73M 8.67M - - 8.57M

South and Latin America

655K 689K - - -

Dach (Germany, Austria, Switzerland)

40.6M 31.88M - - -

The Rest of The Nordic Countries

5.37M 12.11M - - -

EMEA

- - 220M 186M -

France

13.91M 15.27M - - -

ROE (Other Europe)

46.27M 77.98M - - -

Asia

82.07M 83.99M - - -

USA

50.55M 70.75M - - -

Executive Committee: C-Rad AB

Manager TitleAgeSince
Chief Executive Officer 56 2026-02-01
Chief Executive Officer - 2025-10-20
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer 58 2019-10-31
Corporate Officer/Principal 58 2025-10-20

Composition of the Board of Directors: C-Rad AB

Director TitleAgeSince
Director/Board Member 52 2016-12-31
Director/Board Member 60 2021-05-06
Chairman 61 2023-05-04
Director/Board Member 60 2023-05-04
Director/Board Member 66 2023-05-04
Director/Board Member 55 2007-07-22

Shareholders: C-Rad AB

NameStocks%Valuation
Svea Bank AB
11.93 %
3,924,969 11.93 % 15 M $
9.926 %
3,266,170 9.926 % 13 M $
Cervantes Capital AB
9.072 %
2,984,997 9.072 % 11 M $
4.352 %
1,432,078 4.352 % 6 M $
3.647 %
1,200,000 3.647 % 5 M $
NameStocks%Valuation
44.01 %
379,762 44.01 % 1 M $
30.49 %
263,125 30.49 % 1 M $
Cervantes Capital AB
13.91 %
120,000 13.91 % 461 635 $
Svea Bank AB
11.59 %
100,000 11.59 % 384 696 $

Holdings: C-Rad AB

NameStocks%Valuation
188,5000.57% 725 152 $

Company details: C-Rad AB

C-RAD AB

Sjukhusvaegen 12K

753 09, Uppsala

+46 18 666 930

http://www.c-rad.se
address C-Rad AB(CRADF)

Other Advanced Medical Equipment & Technology

Change 5-day change 1-year change 3-year change Capi.($)
+4.16%+1.41%+25.84%+15.24% 218B
+5.97%+1.96%+1.19%-15.87% 140B
+1.67%-0.87%-17.36%+39.09% 138B
+3.05%+1.60%-49.53%+3.63% 73.14B
+1.43%-1.47%+17.85%+20.50% 52.44B
+1.32%+0.99%-15.35%-12.15% 50.85B
+4.70%+3.96%+31.54%+30.32% 41.92B
+3.64%+0.20%+43.69%+54.01% 39.42B
+2.74%+2.57%+1.98%+9.16% 32.81B
Average +2.12%-1.97%+4.43%+15.99% 87.43B
Weighted average by Cap. +2.08%-2.40%+3.86%+13.88%
Trader
Investor
Global
Quality
ESG MSCI
-